Frontlight ResearchEarly access
Psoriatic arthritis trials in France
14 of 22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3CompletedContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Chambray Les Tours, Reims Cedex, Saint-Priest-en-Jarez, Toulouse
- Age
- 18 years and over
- People
- 1,182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - Phase 4Not yet taking people in FranceAn open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Brest, Reims, Toulon Cedex 9, Toulouse
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00 - Phase 2Taking peopleStudy of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Where
- Bordeaux, Caluire-et-Cuire, Chambray-lès-Tours, Nice, Orléans
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- AbbVie
See details and how to joinNCT06865105 - No phaseTaking peopleEfficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis
- Where
- Paris
- Age
- 18 years to 75 years
- People
- 144
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07460739 - Phase 3CompletedA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Bron, Le Kremlin Bicetre Cedex, Nimes Cedex 9, Paris, Poitiers
- Age
- 1 year to 18 years
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 · EU 2023-506131-15-00 - Phase 3Taking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Lille Cedex
- Age
- 3 years to 64 years
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - Phase 3Taking peopleAn Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Where
- Chambray Les Tours, Le Kremlin Bicetre Cedex, Paris, Poitiers
- Age
- 2 years to 18 years
- People
- 40 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00 - Phase 3Taking peopleApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Where
- Bron, Lille Cedex
- Age
- 5 years to 17 years
- People
- 60 worldwide
- Run by
- Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00 - Phase 3Taking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Where
- Bordeaux, Le Kremlin Bicetre Cedex
- Age
- 5 years to 17 years
- People
- 40 worldwide
- Run by
- AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00 - No phaseTaking peopleCytokine Expression in Psoriasis Patients With and Without Joint Involvement
- Where
- Poitiers
- Age
- 18 years to 100 years
- People
- 40
- Run by
- Poitiers University Hospital
See details and how to joinNCT05307809 - No phaseTaking peopleHLA B Leader in Patients With Psoriatic Arthritis
- Where
- Amiens
- Age
- 18 years and over
- People
- 658
- Run by
- Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07718815 - No phaseTaking peopleDeployment o the Multidisciplinary Prospective Cohort Imminent
- Where
- Lille
- Age
- 18 years and over
- People
- 2,200
- Run by
- University Hospital, Lille
See details and how to joinNCT04334031 - Phase 3Not yet taking people in FranceA study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
- Where
- Cahors, Caluire-Et-Cuire, Chambray Les Tours, Echirolles, Montpellier, Narbonne Cedex, Nice, Paris, Rouen Cedex, St Etienne Cedex 2, Toulouse
- Age
- 18 years and over
- People
- 948 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00 - No phaseTaking peopleInfluence of Sodium Intake in spondyLoarthriTes
- Where
- Besançon, La Roche-sur-Yon, Saint-Etienne, Trévenans
- Age
- 18 years to 80 years
- People
- 250
- Run by
- Centre Hospitalier Universitaire de Besancon
See details and how to joinNCT06259890